CRISPR Therapeutics (CRSP) Sees IPO Price of $15 - $17/Share

CRISPR Therapeutics AG (Nasdaq: CRSP) filed an amended registration with the U.S. SEC for an initial public offering of its common stock. The company plans to sell 4.7 million shares and sees an offering price of $15 to $17 per share.

The offering is being made through Citigroup, Piper Jaffray, Barclays, and Guggenheim Securities.

CRISPR Therapeutics is a leading gene editing company focused on the development of CRISPR/Cas9-based therapeutics.

You May Also Be Interested In

• EShallGo closes $1.75M registered direct offering at $1 per share
• reAlpha completes $8.5M InstaMortgage acquisition
• Werewolf Therapeutics to merge with Ambros in $150M private placement